Hachiya Rumi, Ohashi Yuko, Kamei Yasutomi, Suganami Takayoshi, Mochizuki Hiroshi, Mitsui Norimasa, Saitoh Masaaki, Sakuragi Masako, Nishimura Gen, Ohashi Hirofumi, Hasegawa Tomonobu, Ogawa Yoshihiro
Department of Pediatrics, Keio University School of Medicine, 160-8582 Tokyo, Japan.
J Clin Endocrinol Metab. 2007 Oct;92(10):4009-14. doi: 10.1210/jc.2007-1101. Epub 2007 Jul 24.
Natriuretic peptide receptor-B (NPR-B, GC-B in rodents; gene name NPR2) is a guanylyl cyclase-coupled receptor that mediates the effect of C-type natriuretic peptide. Homozygous mutations in human NPR-B cause acromesomelic dysplasia, type Maroteaux (OMIM 602875), an autosomal recessive skeletal dysplasia. NPR-B has an intracellular kinase homology domain (KHD), which has no kinase activity, and its functional significance in vivo is currently unknown.
We examined the functional significance of a novel NPR-B KHD mutation in humans.
A 28-yr-old Japanese male presented with marked short stature (118.5 cm, -9.3 sd). His limbs showed marked shortening in the middle and distal segments. His parents had relatively short stature with height z-scores of -2.75 and -0.98 (his father and mother, respectively). Direct sequencing of coding region of the NPR2 gene of the family was performed. The mutant receptor activity was investigated by saturation binding assay and cGMP measurement. Additionally, interaction between the mutant and wild type allele was investigated by the titration experiments.
We identified a novel missense mutation L658F in KHD of NPR-B in homozygous and heterozygous states in the patient and his parents, respectively. The mutation conferred normal binding affinity for C-type natriuretic peptide but no discernible ligand-induced cGMP production. Furthermore, L658F mutant impaired wild-type NPR-B-mediated cGMP production in a dose-dependent manner, suggesting that short stature found in L658F heterozygote can be caused by its dominant-negative effect.
This study provides the first evidence that intact KHD of NPR-B is essential for skeletal development.
利钠肽受体B(NPR - B,在啮齿动物中为GC - B;基因名称为NPR2)是一种与鸟苷酸环化酶偶联的受体,介导C型利钠肽的作用。人类NPR - B的纯合突变会导致马罗泰克斯型肢端中胚层发育异常(OMIM 602875),这是一种常染色体隐性骨骼发育异常疾病。NPR - B具有一个细胞内激酶同源结构域(KHD),该结构域没有激酶活性,其在体内的功能意义目前尚不清楚。
我们研究了人类中一种新型NPR - B KHD突变的功能意义。
一名28岁的日本男性,身材显著矮小(身高118.5厘米,标准差为 - 9.3)。他的四肢在中段和远端明显缩短。他的父母身材相对矮小,身高z值分别为 - 2.75和 - 0.98(分别为他的父亲和母亲)。对该家族的NPR2基因编码区进行直接测序。通过饱和结合试验和环磷酸鸟苷(cGMP)测量研究突变受体的活性。此外,通过滴定实验研究突变体与野生型等位基因之间的相互作用。
我们在患者及其父母中分别鉴定出一种新型错义突变L658F,该突变在NPR - B的KHD中呈纯合和杂合状态。该突变赋予了对C型利钠肽正常的结合亲和力,但没有可识别的配体诱导的cGMP产生。此外,L658F突变体以剂量依赖性方式损害野生型NPR - B介导的cGMP产生,这表明在L658F杂合子中发现的身材矮小可能是由其显性负效应引起的。
本研究首次提供证据表明NPR - B完整的KHD对骨骼发育至关重要。